欧州の液体クロマトグラフィー装置サービス市場調査レポート:サービスタイプ別(メンテナンス、設置、定期試験サービス、サポートサービス、その他)、エンドユーザー別(製薬会社、バイオ製薬会社、契約研究機関、その他)、地域別(ドイツ、フランス、アイルランド、英国、スペイン、イタリア、スイス、その他ヨーロッパ)、2030年までの地域別予測
Europe Liquid Chromatography Instruments Services Market Research Report Information by Service Type (Maintenance, Installation, Routine Testing Services, Support Services, Others), by End-Use (Pharmaceutical Companies, Biopharmaceutical Companies, Contract Research Organizations, Others), by Region (Germany, France, Ireland, UK, Spain, Italy, Switzerland, Rest of Europe) Regional Forecast till 2030
欧州の液体クロマトグラフィー装置サービス市場調査レポート:サービスタイプ別(メンテナンス、設置、定期試験サービス、サポートサービス、その他)、エンドユーザー別(製薬会社、バイオ製薬会社、契約研究機... もっと見る
サマリー 欧州の液体クロマトグラフィー装置サービス市場調査レポート:サービスタイプ別(メンテナンス、設置、定期試験サービス、サポートサービス、その他)、エンドユーザー別(製薬会社、バイオ製薬会社、契約研究機関、その他)、地域別(ドイツ、フランス、アイルランド、英国、スペイン、イタリア、スイス、その他ヨーロッパ)、2030年までの地域別予測
市場概要
欧州の液体クロマトグラフィ機器サービス市場は2021年に5億7,642万米ドルとなった。欧州液体クロマトグラフィ機器サービス市場は、2022年から2030年までの予測期間中に7.07%の複合年間成長率(CAGR)で成長し、2030年には10億9612万米ドルに達すると予測される。
欧州の液体クロマトグラフィー装置サービス市場の主な促進要因としては、先端医薬品開発への投資の増加や高性能分析ツールに対する需要の高まりが挙げられる。欧州の旺盛な医薬品R&D投資は、液体クロマトグラフィーのサービス稼働率と効率性を高めている。また、創薬の複雑化に伴い、逆相液体クロマトグラフィー(RPLC)や超高性能液体クロマトグラフィー(UHPLC)などの高度な技術の採用が加速しています。これらの技術はスループットと分離能を向上させ、製薬、バイオテクノロジー、食品、環境分野にとって不可欠なものとなっており、最終的にこの地域全体で高度な機器サービスの必要性を高めている。
熟練した専門家の不足と高い人件費がこの地域の市場成長の妨げとなっており、企業は非効率で時間のかかる研究をアウトソーシングすることを余儀なくされている。モノクローナル抗体のようなタンパク質バイオ医薬品の需要増加を背景に、クロマトグラフィーの進歩が新たな機会を生み出している。分析ニーズの進化により、革新的なHPLCカラムと技術が開発され、生体分子、キラル医薬品、汚染物質の検出性能の向上により医薬品分析が強化され、バイオ医薬品研究におけるクロマトグラフィーの役割が拡大しています。
市場セグメント
サービスタイプ別に見ると、欧州の液体クロマトグラフィ機器サービス市場は、設置、ルーチン検査サービス、メンテナンス、サポートサービス、その他に区分される。
欧州の液体クロマトグラフィ機器サービス市場は、製薬会社、バイオ製薬会社、受託研究機関、その他などのエンドユーズセグメントに分類される。
地域別では、欧州液体クロマトグラフィ機器サービス市場はドイツ、フランス、アイルランド、英国、スペイン、イタリア、スイス、その他欧州に分類される。
主要プレイヤー
Danaher Corporation、Waters Corporation、KRSS Europe B.V.、Thermo Fisher Scientific Inc.、PerkinElmer, Inc.、Agilent Technologies Inc.、JASCO、島津製作所、KNAUER Wissenschaftliche Geräte GmbH、BUCHIが欧州液体クロマトグラフィー装置サービス業界の主要企業です。
ページTOPに戻る
目次 目次
2.
2.
2.
2.
2.
3.
3.
3.
3.
3.
3.
3.
3.
3.
3.
4.
4.
4.
4.
4.
4.
4.
4.
5.
5.
5.
5.
5.
5.
5.
5.
5.
5.
5.
5.
5.
5.
6 欧州の液体クロマトグラフィー機器サービス市場
6.
6.
6.
6.
6.
6.
7 欧州液体クロマトグラフィー機器サービス市場
7.
7.
7.
7.
7.
8.
8.
8.
8.
8.
8.
8.
8.
8.
9.
9.
9.
9.
9.
10.1 サーモフィッシャーサイエンティフィック
10.
10.
10.
10.
10.
10.
10.2 アジレント・テクノロジー株式会社
10.
10.
10.
10.
10.
10.
10.3 パーキネルマー株式会社........................................................................................................................................................... 61
10.
10.
10.
10.
10.
10.
10.
10.
10.
10.
10.
10.
10.
10.
10.
10.
10.
10.
10.
10.
10.
10.
10.
10.
10.
10.
10.
10.
10.
10.
10.
10.
10.8 KRSS EUROPE B.V. .....................................................................................................................................................................................................................................................................
10.
10.
10.
10.
10.
10.
10.
10.
10.
10.
10.
10.
10.
10.
10.
10.
10.
11.
11.
ページTOPに戻る
Summary Europe Liquid Chromatography Instruments Services Market Research Report Information by Service Type (Maintenance, Installation, Routine Testing Services, Support Services, Others), by End-Use (Pharmaceutical Companies, Biopharmaceutical Companies, Contract Research Organizations, Others), by Region (Germany, France, Ireland, UK, Spain, Italy, Switzerland, Rest of Europe) Regional Forecast till 2030
Market Overview Europe liquid chromatography instruments services market was valued at USD 576.42 million in 2021. Europe liquid chromatography instruments service market is projected to reach USD 1,096.12 million by 2030, growing at a compound annual growth rate (CAGR) of 7.07% during the forecast period from 2022 to 2030. Key drivers of the Europe liquid chromatography instruments service market include increased investment in advanced drug development and rising demand for high-performance analytical tools. Europe’s strong pharmaceutical R&D spending is enhancing service availability and efficiency in liquid chromatography. Additionally, the growing complexity of drug discovery has accelerated the adoption of advanced techniques like Reversed-Phase Liquid Chromatography (RPLC) and Ultra-High Performance Liquid Chromatography (UHPLC). These technologies offer improved throughput and resolution, making them essential for pharmaceutical, biotech, food, and environmental sectors, ultimately boosting the need for advanced instrument services across the region. A shortage of skilled professionals and high labor costs hinder the regional market growth, prompting companies to outsource research, which is often inefficient and time-consuming. Advancements in chromatography, driven by rising demand for protein biopharmaceuticals like monoclonal antibodies, are creating new opportunities. Evolving analytical needs have led to innovative HPLC columns and techniques, enhancing pharmaceutical analysis through improved performance in detecting biomolecules, chiral drugs, and contaminants, thereby expanding chromatography’s role in biopharma research.
Market Segmentations In terms of service type, Europe liquid chromatography instruments services market has been segmented into installation, routine testing services, maintenance, support service, and others. Europe liquid chromatography instruments services market is categorized by the end-use segments, it includes pharmaceutical companies, biopharmaceutical companies, contract research organizations, and others. Regionally, Europe liquid chromatography instruments service market is divided into Germany, France, Ireland, UK, Spain, Italy, Switzerland, Rest of Europe.
Major Players Danaher Corporation, Waters Corporation, KRSS Europe B.V., Thermo Fisher Scientific Inc., PerkinElmer, Inc., Agilent Technologies Inc., JASCO, Shimadzu Corporation, KNAUER Wissenschaftliche Geräte GmbH, BUCHI are the major players of Europe liquid chromatography instruments service industry.
ページTOPに戻る
Table of Contents TABLE OF CONTENTS 1 EXECUTIVE SUMMARY ............................................................................................................... 11 2 MARKET INTRODUCTION ............................................................................................................ 12 2.1 DEFINITION ....................................................................................................................................................................... 12 2.2 SCOPE OF THE STUDY ...................................................................................................................................................... 12 2.3 RESEARCH OBJECTIVE ..................................................................................................................................................... 12 2.4 MARKET STRUCTURE ....................................................................................................................................................... 13 2.5 ASSUMPTIONS & LIMITATIONS ........................................................................................................................................ 13 3 RESEARCH METHODOLOGY ...................................................................................................... 14 3.1 DATA MINING .................................................................................................................................................................... 14 3.2 SECONDARY RESEARCH ................................................................................................................................................... 15 3.3 PRIMARY RESEARCH ........................................................................................................................................................ 16 3.4 BREAKDOWN OF PRIMARY RESPONDENTS ..................................................................................................................... 17 3.5 FORECASTING TECHNIQUES ............................................................................................................................................ 17 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION ........................................................................................ 19 3.6.1 BOTTOM-UP APPROACH .............................................................................................................................................. 20 3.6.2 TOP-DOWN APPROACH ................................................................................................................................................ 20 3.7 DATA TRIANGULATION ..................................................................................................................................................... 21 3.8 VALIDATION ...................................................................................................................................................................... 21 4 MARKET DYNAMICS .................................................................................................................... 22 4.1 OVERVIEW ......................................................................................................................................................................... 22 4.2 DRIVERS ............................................................................................................................................................................ 22 4.2.1 INCREASED INVESTMENT IN ADVANCED DRUGS ....................................................................................................... 22 4.2.2 RISING DEMAND FOR ADVANCED INSTRUMENT SERVICES ....................................................................................... 23 4.3 RESTRAINTS ..................................................................................................................................................................... 24 4.3.1 LACK OF SKILLED PERSONNEL .................................................................................................................................... 24 4.4 OPPORTUNITIES ............................................................................................................................................................... 25 4.4.1 INCREASED DEMAND FOR PROTEIN BIOPHARMACEUTICALS .................................................................................... 25 5 MARKET FACTOR ANALYSIS ...................................................................................................... 26 5.1 VALUE CHAIN ANALYSIS .................................................................................................................................................. 26 5.1.1 CUSTOMER ACQUISITION (PREPURCHASE QUERY) .................................................................................................... 27 5.1.2 SERVICE CUSTOMIZATION ........................................................................................................................................... 27 5.1.3 CUSTOMER PURCHASE SUPPORT ............................................................................................................................... 27 5.1.4 CUSTOMER FULFILMENT & POST-PURCHASE SUPPORT............................................................................................ 27 5.2 PORTER'S FIVE FORCES MODEL ....................................................................................................................................... 28 5.2.1 THREAT OF NEW ENTRANTS ....................................................................................................................................... 29 5.2.2 BARGAINING POWER OF SUPPLIERS ........................................................................................................................... 29 5.2.3 THREAT OF SUBSTITUTES ........................................................................................................................................... 29 5.2.4 BARGAINING POWER OF BUYERS ................................................................................................................................ 29 5.2.5 INTENSITY OF RIVALRY ................................................................................................................................................ 29 5.3 IMPACT OF COVID-19 ON LIQUID CHROMATOGRAPHY INSTRUMENTS SERVICES MARKET ......................................... 30 5.3.1 OVERVIEW .................................................................................................................................................................... 30 5.3.2 IMPACT ON DEMAND FOR LIQUID CHROMATOGRAPHY INSTRUMENTS SERVICES .................................................. 30 6 EUROPE LIQUID CHROMATOGRAPHY INSTRUMENTS SERVICES MARKET, BY SERVICE TYPE ....................................................................................................................... 31 6.1 OVERVIEW ......................................................................................................................................................................... 31 6.2 MAINTENANCE.................................................................................................................................................................. 33 6.3 INSTALLATION .................................................................................................................................................................. 34 6.4 ROUTINE TESTING SERVICES ........................................................................................................................................... 34 6.5 SUPPORT SERVICES ......................................................................................................................................................... 35 6.6 OTHERS ............................................................................................................................................................................. 35 7 EUROPE LIQUID CHROMATOGRAPHY INSTRUMENTS SERVICES MARKET, BY END USER .............................................................................................................................. 36 7.1 OVERVIEW ......................................................................................................................................................................... 36 7.2 PHARMACEUTICAL COMPANIES ...................................................................................................................................... 38 7.3 BIOPHARMACEUTICAL COMPANIES ................................................................................................................................ 39 7.4 CONTRACT RESEARCH ORGANIZATIONS ........................................................................................................................ 39 7.5 OTHERS ............................................................................................................................................................................. 40 8 EUROPE LIQUID CHROMATOGRAPHY INSTRUMENTS SERVICES MARKET, BY COUNTRY ............................................................................................................................... 41 8.1 OVERVIEW ......................................................................................................................................................................... 41 8.2 GERMANY .......................................................................................................................................................................... 44 8.3 FRANCE ............................................................................................................................................................................. 45 8.4 IRELAND ............................................................................................................................................................................ 46 8.5 UK ...................................................................................................................................................................................... 47 8.6 SPAIN ................................................................................................................................................................................ 48 8.7 ITALY ................................................................................................................................................................................. 49 8.8 SWITZERLAND .................................................................................................................................................................. 50 8.9 REST OF EUROPE .............................................................................................................................................................. 51 9 COMPETITIVE LANDSCAPE ........................................................................................................ 52 9.1 OVERVIEW ......................................................................................................................................................................... 52 9.2 COMPETITIVE BENCHMARKING ....................................................................................................................................... 53 9.3 FINANCIAL MATRIX........................................................................................................................................................... 54 9.3.1 SALES (USD MILLION), 2021 ........................................................................................................................................ 54 9.3.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2021 ........................................................................... 54 10 COMPANY PROFILES .................................................................................................................. 55 10.1 THERMO FISHER SCIENTIFIC INC. ................................................................................................................................... 55 10.1.1 COMPANY OVERVIEW .................................................................................................................................................. 55 10.1.2 FINANCIAL OVERVIEW ................................................................................................................................................. 56 10.1.3 SERVICES OFFERED ..................................................................................................................................................... 56 10.1.4 KEY DEVELOPMENTS ................................................................................................................................................... 56 10.1.5 SWOT ANALYSIS ........................................................................................................................................................... 57 10.1.6 KEY STRATEGIES .......................................................................................................................................................... 57 10.2 AGILENT TECHNOLOGIES, INC. ........................................................................................................................................ 58 10.2.1 COMPANY OVERVIEW .................................................................................................................................................. 58 10.2.2 FINANCIAL OVERVIEW ................................................................................................................................................. 58 10.2.3 SERVICES OFFERED ..................................................................................................................................................... 59 10.2.4 KEY DEVELOPMENTS ................................................................................................................................................... 59 10.2.5 SWOT ANALYSIS ........................................................................................................................................................... 59 10.2.6 KEY STRATEGIES .......................................................................................................................................................... 60 10.3 PERKINELMER INC. ........................................................................................................................................................... 61 10.3.1 COMPANY OVERVIEW .................................................................................................................................................. 61 10.3.2 FINANCIAL OVERVIEW ................................................................................................................................................. 61 10.3.3 SERVICES 0FFERED ...................................................................................................................................................... 61 10.3.4 KEY DEVELOPMENTS ................................................................................................................................................... 62 10.3.5 SWOT ANALYSIS ........................................................................................................................................................... 62 10.3.6 KEY STRATEGIES .......................................................................................................................................................... 62 10.4 JASCO ............................................................................................................................................................................... 63 10.4.1 COMPANY OVERVIEW .................................................................................................................................................. 63 10.4.2 FINANCIAL ANALYSIS................................................................................................................................................... 63 10.4.3 SERVICES OFFERED ..................................................................................................................................................... 63 10.4.4 KEY DEVELOPMENTS ................................................................................................................................................... 63 10.4.5 KEY STRATEGIES .......................................................................................................................................................... 63 10.5 DANAHER CORPORATION ................................................................................................................................................. 64 10.5.1 COMPANY OVERVIEW .................................................................................................................................................. 64 10.5.2 FINANCIAL OVERVIEW ................................................................................................................................................. 64 10.5.3 SERVICES OFFERED ..................................................................................................................................................... 64 10.5.4 KEY DEVELOPMENTS ................................................................................................................................................... 65 10.5.5 KEY STRATEGIES .......................................................................................................................................................... 65 10.6 WATERS CORPORATION ................................................................................................................................................... 66 10.6.1 COMPANY OVERVIEW .................................................................................................................................................. 66 10.6.2 FINANCIAL OVERVIEW ................................................................................................................................................. 66 10.6.3 SERVICES OFFERED ..................................................................................................................................................... 67 10.6.4 KEY DEVELOPMENTS ................................................................................................................................................... 67 10.6.5 SWOT ANALYSIS ........................................................................................................................................................... 67 10.6.6 KEY STRATEGIES .......................................................................................................................................................... 68 10.7 SHIMADZU CORPORATION ............................................................................................................................................... 69 10.7.1 COMPANY OVERVIEW .................................................................................................................................................. 69 10.7.2 FINANCIAL OVERVIEW ................................................................................................................................................. 69 10.7.3 SERVICES OFFERED ..................................................................................................................................................... 70 10.7.4 KEY DEVELOPMENTS ................................................................................................................................................... 70 10.7.5 SWOT ANALYSIS ........................................................................................................................................................... 70 10.7.6 KEY STRATEGIES .......................................................................................................................................................... 71 10.8 KRSS EUROPE B.V. ............................................................................................................................................................ 72 10.8.1 COMPANY OVERVIEW .................................................................................................................................................. 72 10.8.2 FINANCIAL OVERVIEW ................................................................................................................................................. 72 10.8.3 SERVICES OFFERED ..................................................................................................................................................... 72 10.8.4 KEY DEVELOPMENTS ................................................................................................................................................... 72 10.8.5 KEY STRATEGIES .......................................................................................................................................................... 72 10.9 KNAUER WISSENSCHAFTLICHE GERÄTE GMBH ............................................................................................................. 73 10.9.1 COMPANY OVERVIEW .................................................................................................................................................. 73 10.9.2 FINANCIAL OVERVIEW ................................................................................................................................................. 73 10.9.3 SERVICES OFFERED ..................................................................................................................................................... 73 10.9.4 KEY DEVELOPMENTS ................................................................................................................................................... 73 10.9.5 KEY STRATEGIES .......................................................................................................................................................... 73 10.10 BUCHI ................................................................................................................................................................................ 74 10.10.1 COMPANY OVERVIEW .................................................................................................................................................. 74 10.10.2 FINANCIAL OVERVIEW ................................................................................................................................................. 74 10.10.3 SERVICES OFFERED ..................................................................................................................................................... 74 10.10.4 KEY DEVELOPMENTS ................................................................................................................................................... 74 10.10.5 KEY STRATEGIES .......................................................................................................................................................... 74 11 APPENDIX..................................................................................................................................... 75 11.1 REFERENCES ..................................................................................................................................................................... 75 11.2 RELATED REPORTS ........................................................................................................................................................... 75
ページTOPに戻る
Market Research Future社の 医療分野 での最新刊レポート
-
抗肥満薬市場調査レポート:治療タイプ別(セロトニン・ノルエピネフリン再取り込み阻害薬、選択的セロトニン2C受容体作動薬、ノルエピネフリン・ドパミン再取り込み阻害薬)、リパーゼ阻害薬、GLP-1受容体作動薬、併用薬、その他)、薬物タイプ別(処方薬、市販薬)、作用機序別(中枢性抗肥満薬、末梢性抗肥満薬)、投与経路別(経口、皮下)、流通チャネル別(病院薬局、小売薬局、オンライン薬局)、地域別(北米、欧州、アジア太平洋、南米、中東、アフリカ) 2035年までの予測
-
ジェネリック医薬品市場調査レポート:適応症別(中枢神経系(CNS)、循環器、泌尿器、腫瘍、呼吸器、その他)、投与経路別(経口、局所、非経口、その他)、流通チャネル別(病院薬局、小売薬局、オンライン薬局)、地域別(北米、欧州、アジア太平洋地域、その他の地域) 2035年までの予測
-
多発性硬化症治療装置市場調査レポート:タイプ別[原発性進行性多発性硬化症(PPMS)、二次性進行性多発性硬化症(SPMS)、再発寛解型多発性硬化症(RRMS)、臨床的孤立症候群(CIS)]、治療装置別[電気刺激装置(機能的電気刺激(FES)、経皮的電気神経刺激(TENS), 神経刺激装置(脊髄刺激(SCS), 脳深部刺激(DBS))]、エンドユーザー別(病院&クリニック, 外来手術センター)、地域別(北米, 欧州, アジア太平洋, 南米, 中東およびアフリカ)2032年までの予測
-
Peptide Cosmetic API Research Report by Application (Anti-Aging & Wrinkle Reduction, Skin Repair & Regeneration, Moisturizing & Hydration, Whitening & Brightening, Hair Care, Anti-Inflammatory & Soothing), by Source (Plant-Derived Peptides, Animal-Derived Peptides, Bioengineered Peptides, Chemically Synthesized), by End-Use Industry (Skincare, Haircare, Injectable Cosmetics, Others), by Region (North America, Europe, APAC, South America, MEA) Forecast till 2035
-
Ischemic Stroke Surgery Market Research Report by Type of Surgery (Thrombectomy, Revascularization Surgery, Carotid Endarterectomy, Angioplasty, Others), by Product Type (Catheters, Aspiration System, Guidewire, Microcatheter, Others), by End-User (Hospitals and Clinics, Ambulatory Surgical Centers, Others), and by Region (North America, Europe, Asia Pacific, Rest of the World) Forecast till 2035
-
アフリカの動物用医薬品市場レポート 動物種別(動物、コンパニオンアニマル)、製品別(医薬品、ワクチン、飼料添加物、衛生用品、診断薬)、流通チャネル別(小売薬局、Eコマース、その他)、地域別(エジプト、ナイジェリア、アルジェリア、チュニジア、リビア、ウガンダ、タンザニア、南スーダン、ケニア、エチオピア、アフリカのその他)の調査レポート情報 2032年までの予測
-
アルテスネート注射剤の世界市場調査レポート:純度別(アルテスネート0.99、アルテスネート0.98)、用途別(マラリア、重症マラリア、脳マラリア、合併症のないマラリア、その他の用途)、エンドユーザー別(病院、診療所、薬局、政府機関、非政府組織)、流通チャネル別(直販、流通業者および卸売業者、小売薬局、オンライン販売)、地域別(北米、欧州、APAC、南米、MEA)2032年までの予測
-
欧州液体クロマトグラフィー機器サービス市場2030年までの予測調査レポート
-
アーユルヴェーダ市場
-
アジア太平洋地域の血液病理学用バイオマーカー市場調査レポート情報:タイプ別(製品・サービス)、癌タイプ別(リンパ腫、白血病)、技術カテゴリー別(NGS、PCR、IHC、FISH、その他)、2032年までの地域別予測
よくあるご質問
Market Research Future社はどのような調査会社ですか?
マーケットリサーチフューチャー(Market Research Future)は世界市場を幅広く調査し、主要分野、地域、国レベルの調査レポートを出版しています。
下記分野については、分野毎に専... もっと見る
調査レポートの納品までの日数はどの程度ですか?
在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。
注文の手続きはどのようになっていますか?
1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。
お支払方法の方法はどのようになっていますか?
納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。
データリソース社はどのような会社ですか?
当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。
|
|